Is There a Single Marketplace for All Science Software?

This and other PathOS case studies highlight the need for better curation of data sets, which vary widely in ease of use, Grypari says. Many lack the software code and other information needed for users to utilize the data effectively.

From Neil Lawrence, DeepMind Professor of Machine Learning, University of Cambridge; Chair, ai@cam, Cambridge, UK

LibreOffice is the extant branch of the discontinued OpenOffice that some of you may be familiar with. It has almost all the features of Microsoft Office, including a word processor, a spreadsheet program, and a program for making presentations. It does not, however, have a replacement of OneNote (see Tech Corner in Notes from the Field Volume 10 Issue 1).

The SRSC provides affordable access to both specialized and widely used applications common in the physical sciences and engineering, with full-time specialist Misha Guy helping investigators maximize these resources. Available to all FAS faculty, postdoctoral researchers, and graduate students, ...

Worldwide science and technology market analysis, technical insights and industry reports.

For one thing, Barr points out, academia doesn't teach programmers what they actually need to know to do their jobs: how to work in a team to create code that works reliably and can be maintained by somebody other than the original authors. As the size and complexity of commercial software have grown, the gap between academic computer science and industry has widened.

Best for: Scientists, engineers, and researchers in academia or industry needing advanced numerical analysis, simulation, and modeling tools. Pricing: Perpetual base license ~$2,150 + $860/year maintenance; annual subscriptions from $1,000+; academic discounts and campus-wide licenses available. ... Open-source platform that manages Python and R environments, packages, and dependencies for data science and scientific computing.anaconda.com

The global software market size was valued at USD 823.92 billion in 2025 and is anticipated to hit around USD 2,468.93 billion by 2035 with a CAGR of 11.60%.

End-User Segmentation: By end-user, ... functions. Fortune specifically observes that “biotechnology and pharmaceutical companies register the largest revenue share” ([28])....